Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
作者信息
Nayler J H
出版信息
J Antimicrob Chemother. 1987 Jun;19(6):713-32. doi: 10.1093/jac/19.6.713.
PMID:3301784
Abstract
摘要
相似文献
1
Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
J Antimicrob Chemother. 1987 Jun;19(6):713-32. doi: 10.1093/jac/19.6.713.
2
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.
Antimicrob Agents Chemother. 1986 Jul;30(1):1-5. doi: 10.1128/AAC.30.1.1.
3
Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):562-7. doi: 10.1177/106002808602000711.
4
[Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
Nihon Rinsho. 1991 Oct;49(10):2254-60.
5
MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
J Antimicrob Chemother. 1998 May;41(5):513-25. doi: 10.1093/jac/41.5.513.
6
Role of permeability barriers in resistance to beta-lactam antibiotics.
Pharmacol Ther. 1985;27(2):197-231. doi: 10.1016/0163-7258(85)90069-5.
7
[Penicillin-binding proteins. Their enzymatic activity and properties].
Antibiot Med Biotekhnol. 1986 Jul;31(7):487-98.
8
[Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
Pharm Unserer Zeit. 1996 Jan;25(1):17-27. doi: 10.1002/pauz.19960250107.
9
Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--II. Non-steady-state treatment and progress curves.
Biochem Pharmacol. 1989 May 1;38(9):1427-33. doi: 10.1016/0006-2952(89)90181-0.
引用本文的文献
1
A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.
Antimicrob Agents Chemother. 1999 Aug;43(8):1924-31. doi: 10.1128/AAC.43.8.1924.
2
Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance.
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):778-9. doi: 10.1007/BF01975047.
3
Size of diffusion pore of Alcaligenes faecalis.
Antimicrob Agents Chemother. 1988 Mar;32(3):378-84. doi: 10.1128/AAC.32.3.378.
4
Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli.
Antimicrob Agents Chemother. 1989 Mar;33(3):382-6. doi: 10.1128/AAC.33.3.382.
5
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
Antimicrob Agents Chemother. 1989 May;33(5):624-34. doi: 10.1128/AAC.33.5.624.
6
Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1990 Nov;34(11):2093-6. doi: 10.1128/AAC.34.11.2093.
7
In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.
Antimicrob Agents Chemother. 1992 Mar;36(3):589-97. doi: 10.1128/AAC.36.3.589.
Zotero 插件